A metabolite of rivastigmine
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)
Quinupristin-Dalfopristin Complex (mesylate)
¥2560.00 ¥3200.00
Tankyrase Inhibitors (TNKS) 49
¥1320.00 ¥1650.00
没有评价数据